BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3829106)

  • 1. [Left ventricular relaxation in hypertrophic cardiomyopathy and possibilities of controlling it with verapamil].
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cas Lek Cesk; 1987 Mar; 126(11):330-4. PubMed ID: 3829106
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of verapamil on the indicators of left-ventricular diastole in hypertrophic cardiomyopathy].
    Dabrowski M; Górecka B; Witkowski A; Jodkowski J; Woroszylska M; Ruzyłło W
    Kardiol Pol; 1986; 29(5-6):345-55. PubMed ID: 3784250
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relaxation and regional myocardial stiffness in obstructive hypertrophic cardiopathy patients: effect of verapamil].
    Bonandi L; Hess OM; Grimm J; Krayenbühl HP
    G Ital Cardiol; 1984 Feb; 14(2):77-84. PubMed ID: 6538857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of verapamil in the treatment of hypertrophic cardiomyopathy.
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cor Vasa; 1986; 28(6):404-12. PubMed ID: 3829686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of verapamil on systolic time intervals and relaxation time in hypertrophic cardiomyopathy (author's transl)].
    Hirose K; Shimada T; Matsumura T; Iwata M; Yasunaga K; Hori K; Matsusaka J
    J Cardiogr; 1981 Dec; 11(4):1223-32. PubMed ID: 7201494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of single-dose verapamil on ventricular wall movement in hypertrophic cardiomyopathy].
    Wang AA; Gu FS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Feb; 15(1):25-6. PubMed ID: 3608781
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.
    Anderson DM; Raff GL; Ports TA; Brundage BH; Parmley WW; Chatterjee K
    Br Heart J; 1984 May; 51(5):523-9. PubMed ID: 6539120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Doppler evaluation of left ventricular diastolic filling after intravenous injection of verapamil in patients with hypertrophic cardiomyopathy].
    Jin L; Zhu WL; Mu JL
    Zhonghua Nei Ke Za Zhi; 1988 Jul; 27(7):412-4, 454. PubMed ID: 3064997
    [No Abstract]   [Full Text] [Related]  

  • 9. [Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl].
    Lemke R; Hopf R; Kober G; Kaltenbach M
    Z Kardiol; 1980 Oct; 69(10):661-8. PubMed ID: 7192909
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)].
    Kuhn H; Thelen U; Leuner C; Köhler E; Bluschke V
    Z Kardiol; 1980 Oct; 69(10):669-75. PubMed ID: 7192910
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of verapamil on the left ventricular function in hypertrophic obstructive cardiomyopathy].
    Guo HS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Mar; 12(1):13-6. PubMed ID: 6540163
    [No Abstract]   [Full Text] [Related]  

  • 12. Pressure-derived indices of left ventricular isovolumic relaxation in patients with hypertrophic cardiomyopathy.
    Thompson DS; Wilmshurst P; Juul SM; Waldron CB; Jenkins BS; Coltart DJ; Webb-Peploe MM
    Br Heart J; 1983 Mar; 49(3):259-67. PubMed ID: 6681978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy.
    Hanrath P; Mathey DG; Kremer P; Sonntag F; Bleifeld W
    Am J Cardiol; 1980 Jun; 45(6):1258-64. PubMed ID: 7189640
    [No Abstract]   [Full Text] [Related]  

  • 14. Impaired response of left ventricular relaxation to exercise-induced adrenergic stimulation in patients with hypertrophic cardiomyopathy.
    Izawa H; Yokota M; Nagata K; Iwase M; Sobue T
    J Am Coll Cardiol; 1996 Dec; 28(7):1738-45. PubMed ID: 8962560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between changes in left-ventricular contraction periods caused by ethanol and the functional state of the ventricle].
    Dubiel JP; Bielecki A; Horzela T
    Kardiol Pol; 1980; 23(3):195-204. PubMed ID: 7189562
    [No Abstract]   [Full Text] [Related]  

  • 17. [Noninvasive studies of the systolic phase and left-ventricular myocardial contractility in primary hypertrophic cardiomyopathy].
    Dubiel JP; Bielecki A
    Kardiol Pol; 1984; 27(4):257-65. PubMed ID: 6541727
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
    Kaltenbach M; Hopf R; Kober G; Bussmann WD; Keller M; Petersen Y
    Br Heart J; 1979 Jul; 42(1):35-42. PubMed ID: 573129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular end-diastolic pressure-volume relationships in hypertrophic cardiomyopathy. Changes induced by verapamil.
    Tendera M; Polonski L; Kozielska E
    Chest; 1983 Jul; 84(1):54-7. PubMed ID: 6683147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
    Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.